BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 24007969)

  • 1. Clinical outcome of patients with de novo coronary bifurcation lesions treated with the Tryton Side Branch Stent. The SAFE-TRY prospective multicenter single arm study.
    Tarantini G; La Vecchia L; Galli M; Favero L; D'Amico G; Buja P; Russo F; Cabianca E; Napodano M; Musumeci G; Franceschini E; Grassi G; Pavei A; Bonmassari R; Cernetti C; Spedicato L; Caprioglio F; Reimers B; Isabella G
    Int J Cardiol; 2013 Oct; 168(6):5323-8. PubMed ID: 24007969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry.
    Agostoni P; Foley D; Lesiak M; Belkacemi A; Dens J; Kumsars I; Scott B; Oemrawsingh P; Dubois C; Garcia E; Lefèvre T; Stella PR
    EuroIntervention; 2012 Mar; 7(11):1293-300. PubMed ID: 22433192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.
    Généreux P; Kumsars I; Lesiak M; Kini A; Fontos G; Slagboom T; Ungi I; Metzger DC; Wykrzykowska JJ; Stella PR; Bartorelli AL; Fearon WF; Lefèvre T; Feldman RL; LaSalle L; Francese DP; Onuma Y; Grundeken MJ; Garcia-Garcia HM; Laak LL; Cutlip DE; Kaplan AV; Serruys PW; Leon MB
    J Am Coll Cardiol; 2015 Feb; 65(6):533-43. PubMed ID: 25677311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of a dedicated stent in coronary bifurcations with large side branches: A subanalysis of the randomized TRYTON bifurcation study.
    Généreux P; Kini A; Lesiak M; Kumsars I; Fontos G; Slagboom T; Ungi I; Metzger DC; Wykrzykowska JJ; Stella PR; Bartorelli AL; Fearon WF; Lefèvre T; Feldman RL; Tarantini G; Bettinger N; Minalu Ayele G; LaSalle L; Francese DP; Onuma Y; Grundeken MJ; Garcia-Garcia HM; Laak LL; Cutlip DE; Kaplan AV; Serruys PW; Leon MB
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1231-41. PubMed ID: 26397982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis.
    Magro M; Wykrzykowska J; Serruys PW; Simsek C; Nauta S; Lesiak M; Stanislawska K; Onuma Y; Regar E; van Domburg RT; Grajek S; Geuns RJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):798-806. PubMed ID: 20824767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results From the International Drug Coated Balloon Registry for the Treatment of Bifurcations. Can a Bifurcation Be Treated Without Stents?
    Bruch L; Zadura M; Waliszewski M; Platonic Z; Eränen J; Scheller B; Götting B; Herberger D; Palmieri C; Sinicròpi G; Motz W
    J Interv Cardiol; 2016 Aug; 29(4):348-56. PubMed ID: 27242273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three-dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial.
    Grundeken MJ; Garcia-Garcia HM; Kumsars I; Lesiak M; Kayaert P; Dens J; Stella PR; de Winter RJ; Laak LL; Généreux P; Kaplan AV; Leon MB; Wykrzykowska JJ; Onuma Y; Serruys PW
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):E53-E63. PubMed ID: 27083384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches: Outcomes From the Tryton Confirmatory Study.
    Généreux P; Kumsars I; Schneider JE; Lesiak M; Redfors B; Cornelis K; Selmon MR; Dens J; Hoye A; Metzger DC; Muyldermans L; Slagboom T; Francese DP; Ayele GM; Laak LL; Bartorelli AL; Cutlip DE; Kaplan AV; Leon MB
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1338-46. PubMed ID: 27388820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
    Lefèvre T; Ormiston J; Guagliumi G; Schultheiss HP; Quilliet L; Reimers B; Brunel P; Wijns W; Buettner HJ; Hartmann F; Veldhof S; Miquel K; Su X; van der Giessen WJ
    J Am Coll Cardiol; 2005 Aug; 46(4):592-8. PubMed ID: 16098421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry.
    Magro M; Girasis C; Bartorelli AL; Tarantini G; Russo F; Trabattoni D; D'Amico G; Galli M; Gómez Juame A; de Sousa Almeida M; Simsek C; Foley D; Sonck J; Lesiak M; Kayaert P; Serruys PW; van Geuns RJ
    EuroIntervention; 2013 Mar; 8(11):1259-69. PubMed ID: 23538155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
    Kervinen K; Niemelä M; Romppanen H; Erglis A; Kumsars I; Maeng M; Holm NR; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Helqvist S; Vikman S; Wiseth R; Aarøe J; Jokelainen J; Thuesen L;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1160-5. PubMed ID: 24262616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies.
    Grundeken MJ; Asgedom S; Damman P; Lesiak M; Norell MS; Garcia E; Bethencourt A; Woudstra P; Koch KT; Vis MM; Henriques JP; Onuma Y; Foley DP; Bartorelli AL; Stella PR; Tijssen JG; de Winter RJ; Wykrzykowska JJ
    EuroIntervention; 2013 Jun; 9(2):195-203. PubMed ID: 23360690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: final results of the AGILITY trial.
    Weisz G; Metzger DC; Liberman HA; O'Shaughnessy CD; Douglas JS; Turco MA; Mehran R; Gershony G; Leon MB; Moses JW
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):352-9. PubMed ID: 22927100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
    Dubois C; Adriaenssens T; Ughi G; Wiyono S; Bennett J; Coosemans M; Ferdinande B; Sinnaeve P; D'hooge J; Desmet W
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):E155-64. PubMed ID: 22745031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study.
    Bartorelli AL; Trabattoni D; Almonacid A; Fabbiocchi F; Montorsi P; Galli S; Grancini L; Ravagnani P; Mintz GS; Kaplan AV; Popma JJ; Maehara A
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):544-53. PubMed ID: 25115944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial.
    Berland J; Lefèvre T; Brenot P; Fajadet J; Motreff P; Guerin P; Dupouy P; Schandrin C;
    EuroIntervention; 2015 Dec; 11(8):868-76. PubMed ID: 26696455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double bifurcation lesion treated with double Tryton Sidebranch Stent: first case report.
    Unzué L; García E; Almería C
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E477-81. PubMed ID: 23378273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placement of Tryton Side Branch Stent only; a new treatment strategy for Medina 0,0,1 coronary bifurcation lesions.
    Grundeken MJ; Agostoni P; Lesiak M; Koch KT; Voskuil M; de Winter RJ; Wykrzykowska JJ; Stella PR
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E395-402. PubMed ID: 23554121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-human experience with the Medtronic Bifurcation Stent System.
    Meredith IT; Worthley S; Whitbourn R; Webster M; Fitzgerald PJ; Ormiston J
    EuroIntervention; 2011 Oct; 7(6):662-9. PubMed ID: 21959379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.